 |
|
Identification in 2 Independent Samples of a Novel Schizophrenia Risk Haplotype of the Dystrobrevin Binding Protein Gene (DTNBP1)
N. M. Williams, PhD;
A Preece, BSc (Hons);
D. W. Morris, PhD;
G. Spurlock, PhD;
N. J. Bray, PhD;
M. Stephens, BSc (Hons);
N. Norton, PhD;
H. Williams, BSc (Hons);
M. Clement, BSc (Hons);
S. Dwyer, BSc (Hons);
C. Curran, MRCPsych;
J. Wilkinson, MSc;
V. Moskvina, PhD;
J. L. Waddington, PhD, DSc;
M. Gill, MD, MRCPsych, FTCD;
A. P. Corvin, MB, MRCPsych;
S. Zammit, MRCPsych;
G. Kirov, PhD, MD, MRCPsych;
M. J. Owen, PhD, FRCPsych, FMedSci;
M. C. O'Donovan, PhD, FRCPsych
Arch Gen Psychiatry. 2004;61:336-344.
Context Recent research suggests that variation in the gene encoding dystrobrevin binding protein (DTNBP1) confers susceptibility to schizophrenia. Thus far, no specific risk haplotype has been identified in more than 1 study.
Objectives To confirm DTNBP1 as a schizophrenia susceptibility gene, to identify and replicate specific risk and protective haplotypes, and to explore relationships between DTNBP1 and the phenotype.
Design Genetic association study based on mutation detection and case-control analysis.
Setting All subjects were unrelated and ascertained from general (secondary care) psychiatric inpatient and outpatient services.
Participants The Cardiff, Wales, sample included 708 white subjects from the United Kingdom and Ireland (221 females) who met DSM-IV criteria for schizophrenia and were individually matched for age, sex, and ethnicity to 711 blood donor controls (233 females). Mean ± SD age at first psychiatric contact for cases was 23.6 ± 7.7 years; mean age at ascertainment was 41.8 ± 13.5 years. The Dublin, Ireland, sample included 219 white subjects from the Republic of Ireland who met DSM-III-R criteria for schizophrenia or schizoaffective disorder and 231 controls. The mean age of the Irish cases was 46.0 ± 8.5 years; mean age at first psychiatric contact was 25.2 ± 12.4 years.
Main Outcome Measure Evidence for association between the DTNBP1 locus and schizophrenia.
Results In the Cardiff sample, there was no evidence for association with previously implicated haplotypes but strong evidence for association with multiple novel haplotypes. Maximum evidence was found for a novel 3-marker haplotype (global P<.001), composed of 1 risk haplotype (P = .01) and 2 protective haplotypes, 1 common (P = .006) and 1 rare (P<.001). Specific risk and protective haplotypes were replicated in the Dublin sample (P = .02, .047, and .006, respectively). The only phenotypic variable associated with any haplotype was between the common protective haplotype and higher educational achievement (P = .02, corrected for multiple tests).
Conclusions DTNBP1 is a susceptibility gene for schizophrenia. Specific risk and protective haplotypes were identified and replicated. Association with educational achievement may suggest protection mediated by IQ, although this needs to be confirmed in an independent data set.
From the Department of Psychological Medicine, University of Wales College of Medicine, Cardiff (Drs N. M. Williams, Spurlock, Bray, Norton, Curran, Moskvina, Zammit, Kirov, Owen, and O'Donovan, Messrs Stephens, H. Williams, and Clement, and Mss Preece, Dwyer, and Wilkinson); Neuropsychiatric Genetics Group, Department of Psychiatry, Trinity College, Dublin, Ireland (Drs Morris, Gill, and Corvin); Stanley Research Unit, St Davnet's Hospital, Monaghan, Ireland (Dr Waddington); and Department of Clinical Pharmacology, Royal College of Surgeons, Dublin, Ireland (Dr Waddington).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Analysis of copy number variation using quantitative interspecies competitive PCR
Williams et al.
Nucleic Acids Res 2008;0:gkn495v1-gkn495.
ABSTRACT
| FULL TEXT
Comparing Genes and Phenomenology in the Major Psychoses: Schizophrenia and Bipolar 1 Disorder
Ivleva et al.
Schizophr Bull 2008;34:734-742.
FULL TEXT
Schizophrenia: a common disease caused by multiple rare alleles
McClellan et al.
Br. J. Psychiatry 2007;190:194-199.
ABSTRACT
| FULL TEXT
Association of the Dysbindin Gene With Bipolar Affective Disorder
Breen et al.
Am. J. Psychiatry 2006;163:1636-1638.
ABSTRACT
| FULL TEXT
"A Gene for. . .":The Nature of Gene Action in Psychiatric Disorders
Kendler
Focus 2006;4:391.
ABSTRACT
| FULL TEXT
Genetic variation in DTNBP1 influences general cognitive ability
Burdick et al.
Hum Mol Genet 2006;15:1563-1568.
ABSTRACT
| FULL TEXT
Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?
Gough and O'Donovan
J Psychopharmacol 2005;19:47-55.
ABSTRACT
Relationship Between a High-Risk Haplotype in the DTNBP1 (Dysbindin) Gene and Clinical Features of Schizophrenia
Fanous et al.
Am. J. Psychiatry 2005;162:1824-1832.
ABSTRACT
| FULL TEXT
Is the Dysbindin Gene (DTNBP1) a Susceptibility Gene for Schizophrenia?
Williams et al.
Schizophr Bull 2005;31:800-805.
ABSTRACT
| FULL TEXT
Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression
Bray et al.
Hum Mol Genet 2005;14:1947-1954.
ABSTRACT
| FULL TEXT
"A Gene for...": The Nature of Gene Action in Psychiatric Disorders
Kendler
Am. J. Psychiatry 2005;162:1243-1252.
ABSTRACT
| FULL TEXT
Epidemiology of First-Episode Psychosis: Illustrating the Challenges Across Diagnostic Boundaries Through the Cavan-Monaghan Study at 8 Years
Baldwin et al.
Schizophr Bull 2005;31:624-638.
ABSTRACT
| FULL TEXT
The genetics of schizophrenia and bipolar disorder: dissecting psychosis
Craddock et al.
J. Med. Genet. 2005;42:193-204.
ABSTRACT
| FULL TEXT
Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8
Chen et al.
Hum Mol Genet 2004;13:2991-2995.
ABSTRACT
| FULL TEXT
Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia
Numakawa et al.
Hum Mol Genet 2004;13:2699-2708.
ABSTRACT
| FULL TEXT
Schizophrenia Genetics and Dysbindin: A Corner Turned?
Kendler
Am. J. Psychiatry 2004;161:1533-1536.
FULL TEXT
|
